A planned Medicare pilot program that would have expanded access to popular weight‑loss drugs known as GLP‑1s has been ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer ...
The Centers for Medicare and Medicaid Services (CMS) is rolling out a program this summer that will provide more affordable ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
Manufacturers whose medical devices have been FDA designated as Class III breakthrough devices -- those addressing an unmet ...
Medicare will, for the first time, cover certain weight-loss drugs for qualifying seniors at $50 a month through a new 'GLP-1 Bridge' program. The initiative offers access to costly medications like ...
Louisville companies Cornbread Hemp and Alliant Purchasing are part of a new Medicare pilot program for cannabis products.